Corvus Pharmaceuticals, Inc. — Director's Dealing 2016

Mar 29, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2016-03-29

Reporting Person: Gould Terry P (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-29	Common Stock, $0.0001 par value	C	550864	—	Acquired	550864	Indirect
2016-03-29	Common Stock, $0.0001 par value	C	92278	—	Acquired	643142	Indirect
2016-03-29	Common Stock, $0.0001 par value	P	51712	$15.00	Acquired	694854	Indirect
2016-03-29	Common Stock, $0.0001 par value	C	567121	—	Acquired	567121	Indirect
2016-03-29	Common Stock, $0.0001 par value	C	95001	—	Acquired	662122	Indirect
2016-03-29	Common Stock, $0.0001 par value	P	53239	$15.00	Acquired	715361	Indirect
2016-03-29	Common Stock, $0.0001 par value	C	428998	—	Acquired	428998	Indirect
2016-03-29	Common Stock, $0.0001 par value	C	71863	—	Acquired	500861	Indirect
2016-03-29	Common Stock, $0.0001 par value	P	40272	$15.00	Acquired	541133	Indirect
2016-03-29	Common Stock, $0.0001 par value	C	583510	—	Acquired	583510	Indirect
2016-03-29	Common Stock, $0.0001 par value	C	97746	—	Acquired	681256	Indirect
2016-03-29	Common Stock, $0.0001 par value	P	54777	$15.00	Acquired	736033	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-29	Series A Convertible Preferred Stock	$	C	550864	Disposed		Common Stock (550864)	Indirect
2016-03-29	Series B Convertible Preferred Stock	$	C	92278	Disposed		Common Stock (92278)	Indirect
2016-03-29	Series A Convertible Preferred Stock	$	C	567121	Disposed		Common Stock (567121)	Indirect
2016-03-29	Series B Convertible Preferred Stock	$	C	95001	Disposed		Common Stock (95001)	Indirect
2016-03-29	Series A Convertible Preferred Stock	$	C	428998	Disposed		Common Stock (428998)	Indirect
2016-03-29	Series B Convertible Preferred Stock	$	C	71863	Disposed		Common Stock (71863)	Indirect
2016-03-29	Series A Convertible Preferred Stock	$	C	583510	Disposed		Common Stock (583510)	Indirect
2016-03-29	Series B Convertible Preferred Stock	$	C	97746	Disposed		Common Stock (97746)	Indirect

Footnotes

F1: The Series A Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Issuer's Common Stock, for no additional consideration, on a 1:1 basis at the consummation of Issuer's initial public offering.

F2: Represents shares held directly by Adams Street 2011 Direct Fund LP ("AS 2011"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2011, may be deemed to beneficially own the shares held by AS 2011. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2011. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2011 except to the extent of their pecuniary interest therein.

F3: Represents shares held directly by Adams Street 2012 Direct Fund LP ("AS 2012"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2012, may be deemed to beneficially own the shares held by AS 2012. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2012. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2012 except to the extent of their pecuniary interest therein.

F4: Represents shares held directly by Adams Street 2013 Direct Fund LP ("AS 2013"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2013, may be deemed to beneficially own the shares held by AS 2013. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2013. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2013 except to the extent of their pecuniary interest therein.

F5: Represents shares held directly by Adams Street 2014 Direct Fund LP ("AS 2014"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2014, may be deemed to beneficially own the shares held by AS 2014. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2014. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2014 except to the extent of their pecuniary interest therein.

F6: The expiration date is not relevant to the conversion of these securities.

F7: AS 2011, AS 2012, AS 2013 and AS 2014 purchased an aggregate of 200,000 shares of Issuer's common stock in connection with the initial public offering at the offering price of $15.00 per share.